Marshall Wace
RDY icon

Marshall Wace’s Dr. Reddy's Laboratories RDY Stock Holding History

Marshall Wace’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3M Sell
2,025,356
-638,950
-24% -$8.62M 0.02% 569
2026
Q1 		$36.9M Buy
2,664,306
+2,148,050
+416% +$29.9M 0.04% 468
2025
Q4 		$7.25M Buy
516,256
+487,565
+1,699% +$6.84M 0.01% 996
2025
Q3 		$401K Buy
+28,691
New +$413K ﹤0.01% 2311
2025
Q2 		– Sell
-613,214
Closed -$8.09M – 3080
2025
Q1 		$8.09M Buy
613,214
+599,750
+4,454% +$8.28M 0.01% 855
2024
Q4 		$213K Buy
+13,464
New +$202K ﹤0.01% 2336
2023
Q4 		– Sell
-140,735
Closed -$1.88M – 2535
2023
Q3 		$1.88M Sell
140,735
-1,093,825
-89% -$14.8M ﹤0.01% 1251
2023
Q2 		$15.6M Buy
1,234,560
+1,098,810
+809% +$12.8M 0.03% 571
2023
Q1 		$1.55M Sell
135,750
-107,925
-44% -$1.16M ﹤0.01% 1598
2022
Q4 		$2.52M Buy
+243,675
New +$2.63M 0.01% 1606
2022
Q2 		– Sell
-71,340
Closed -$795K – 3771
2022
Q1 		$795K Buy
+71,340
New +$809K ﹤0.01% 2548
2020
Q1 		– Sell
-714,770
Closed -$5.8M – 1991
2019
Q4 		$5.8M Sell
714,770
-13,320
-2% -$105K 0.04% 482
2019
Q3 		$5.52M Buy
+728,090
New +$5.42M 0.04% 479
2014
Q3 		– Sell
-491,740
Closed -$4.24M – 1013
2014
Q2 		$4.24M Buy
+491,740
New +$4.14M 0.06% 286

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace's RDY Position: Q2 2026 in Review

Marshall Wace reduced its Dr. Reddy's Laboratories (RDY) stake by 24% in Q2 2026, selling an estimated $8.62M and leaving 2,025,356 shares worth $29.3M. The position accounts for 0.02% of the portfolio, ranked #569.

Marshall Wace first reported a position in RDY in Q2 2014 and has held it in 14 quarters since. The position peaked at $36.9M in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Marshall Wace held 2,025,356 shares of Dr. Reddy's Laboratories worth $29.3M as of Q2 2026.
  • Marshall Wace sold 638,950 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $8.62M.
  • Dr. Reddy's Laboratories made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #569 holding.
  • Marshall Wace first reported a position in Dr. Reddy's Laboratories in Q2 2014 and has held it in 14 quarters since.
  • Marshall Wace's Dr. Reddy's Laboratories position peaked at $36.9M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.